TARSIER PHARMA
Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and inflammatory ocular diseases. The TRS Platform Technology is a bio-inspired immunomodulator designed to treat blinding inflammatory ocular diseases and is currently being developed as both eye drops and intravitreal injections. Ocular inflammations are a group of diseases affecting the front and back of the eye... . Non-infectious anterior and posterior uveitis is the most known ocular inflammatory disease. However, ocular inflammation is a critical underlying mechanism in the pathology of other inflammatory eye diseases, such as non-evaporative dry eye, diabetic macular edema (DME), and dry age-related macular degeneration (AMD). Hundreds of millions of people in all age groups are suffering from ocular inflammatory diseases worldwide, conditions that pose severe risks of vision loss and blindness.
TARSIER PHARMA
Industry:
Biopharma Medical Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
Haifa, Hefa, Israel
Country:
Israel
Website Url:
http://www.tarsiuspharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.4 M USD
Technology used in webpage:
SPF Amazon Microsoft Exchange Online Office 365 Mail Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
Artax Biopharma
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Bichen Pharmaceutical
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
dMed
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - Tarsier Pharma
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries investment in Corporate Round - Tarsier Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-28 | Tarsier Pharma Announces the Appointment of Emilee Fulcher as Vice President of Clinical Affairs |
Official Site Inspections
http://www.tarsiuspharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tarsier Pharma"
Tarsier® Pharma
Science & Technology Dazdotuftide (TRS), the Tarsier breakthrough platform technology, approaches inflammatory diseases from within the immune system. Tarsier® Pharma …See details»
Tarsius Pharma Company Profile | Management and Employees …
Tarsius Pharma Profile and History Tarsius Pharma was established in 2016 and is focused on developing TRS, a breakthrough, bio-inspired platform technology for the treatment of blinding …See details»
Investor Relations - Tarsier® Pharma
Jan 16, 2024 Investor Relations Investor Relations CORPORATE PROFILE We are a clinical late-stage pharmaceutical company focused on the development and commercialization of …See details»
Our Leadership | Tarsus
Prior to joining Tarsus, he was a Senior Vice President of Global Pharmaceutical Development at Allergan (an AbbVie company), where he built strong and nimble early development functions …See details»
Tarsius Pharma - Overview, News & Competitors | ZoomInfo.com
View Tarsius Pharma (www.tarsiuspharma.com) location in Haifa, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Tarsius Pharma - Company Profile & Staff Directory | ContactOut
Discover Tarsius Pharma company details, including staff directory, contact information, and industry insights. Explore alternatives, competitors, and frequently asked questions to get …See details»
Tarsier Pharma - Israeli Startup | Startup Nation Finder
Jan 5, 2022 Tarsier Pharma is a late-clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of …See details»
Tarsier Pharma Overview | SignalHire Company Profile
Mar 1, 2022 Tarsier Pharma is a late clinical-stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of …See details»
Tarsier Pharma - VentureRadar
Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and …See details»
Tarsius Pharma - Products, Competitors, Financials, Employees ...
Tarsius Pharma is a late clinical-stage biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory ocular diseases. The company's main …See details»
TARSIUS PHARMA LTD - VentureRadar
Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach for better and safer treatment of autoimmune and …See details»
Tarsius Pharma - CoBee Company Profile & Funding Rounds
Tarsius Pharma is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory ocular diseases.See details»
Tarsier Pharma - Contacts, Employees, Board Members
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.See details»
Tarsier Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Tarsier Pharma. Use the PitchBook Platform to explore the full profile.See details»
Tarsier Pharma - VentureRadar
VentureRadar Research / Company Website Tarsius Pharma is a clinical stage company dedicated to the development and commercialization of a breakthrough therapeutic approach …See details»
Home | Tarsus
Mar 12, 2025 Creating novel therapies, beginning with the eye XDEMVY ® (lotilaner ophthalmic solution) 0.25% is the first and only FDA-approved product for the millions of patients living …See details»
Tarsier Pharma - Funding, Financials, Valuation & Investors
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.See details»
Press Release Distribution and Management - GlobeNewswire
GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.See details»
Our Story | Tarsus
We push boundaries to find new ways forward – for our patients, physicians, employees and communities. Since our founding, we’ve been intentional about doing things differently – from …See details»